CI
RMD icon

Cambiar Investors’s ResMed RMD Stock Holding History

Cambiar Investors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-49,105
Closed -$3.82M – 172
2017
Q2 		$3.82M Sell
49,105
-6,508
-12% -$466K 0.06% 127
2017
Q1 		$4M Sell
55,613
-1,578
-3% -$109K 0.07% 104
2016
Q4 		$3.55M Buy
57,191
+2,503
+5% +$153K 0.06% 117
2016
Q3 		$3.54M Sell
54,688
-5,918
-10% -$394K 0.05% 129
2016
Q2 		$3.83M Buy
60,606
+1,606
+3% +$94.7K 0.05% 116
2016
Q1 		$3.41M Buy
59,000
+6,349
+12% +$359K 0.05% 130
2015
Q4 		$2.83M Buy
52,651
+2,393
+5% +$135K 0.04% 122
2015
Q3 		$2.56M Buy
50,258
+10,191
+25% +$549K 0.04% 140
2015
Q2 		$2.26M Buy
+40,067
New +$2.53M 0.03% 130

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambiar Investors's RMD Position: Q3 2017 in Review

Cambiar Investors sold out of ResMed (RMD) in Q3 2017, closing a stake of 49,105 shares — an estimated $3.82M sold.

Cambiar Investors first reported a position in RMD in Q2 2015 and held it in 9 quarters. The position peaked at $4M in Q1 2017. 362 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

  • Cambiar Investors reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
  • Cambiar Investors sold 49,105 ResMed shares in Q3 2017, an estimated $3.82M.
  • Cambiar Investors first reported a position in ResMed in Q2 2015 and held it in 9 quarters.
  • Cambiar Investors's ResMed position peaked at $4M in Q1 2017.
  • 362 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on Cambiar Investors's 13F filing for Q3 2017, filed 6 Nov 2017.